Cinnamaldehyde Nanoemulsion to Fight MRSA Biofilms
Author Information
Author(s): Yin Lizi, Guo Yingzi, Xv Xiyuan, Dai Yuyun, Li Luxin, Sun Fengsheng, Lv Xue, Shu Gang, Liang Xiaoxia, He Changliang, Xu Zhiwen, Ouyang Ping
Primary Institution: College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, China
Hypothesis
Can a cinnamaldehyde nanoemulsion combined with rhamnolipid effectively inhibit methicillin-resistant Staphylococcus aureus (MRSA) biofilm formation?
Conclusion
The cinnamaldehyde nanoemulsion with rhamnolipid effectively eradicates MRSA biofilms and shows potential for treating persistent bacterial infections.
Supporting Evidence
- The nanoemulsion showed a minimum inhibitory concentration (MIC) of 512 μg/mL against MRSA.
- Cin-RHL-NE reduced MRSA biofilm proliferation by 66.9% at a concentration of 256 μg/mL.
- Histological analysis showed significant reduction in inflammation in the Cin-RHL-NE treatment group.
- Scanning Electron Microscopy (SEM) revealed severe damage to MRSA cells treated with the nanoemulsion.
Takeaway
This study shows that a special mixture of cinnamon oil and a natural surfactant can help kill stubborn bacteria that form protective layers.
Methodology
The study used in vitro assays and in vivo experiments with a mouse skin wound healing model to assess the efficacy of the cinnamaldehyde nanoemulsion.
Limitations
The mechanisms of how the nanoemulsion dismantles MRSA biofilms are not fully understood.
Participant Demographics
SPF BALB/c mice (8-weeks old, 18–20 g) were used in the in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website